Your browser is no longer supported. Please, upgrade your browser.
Settings
CTXR Citius Pharmaceuticals, Inc. daily Stock Chart
CTXR [NASD]
Citius Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.64 Insider Own39.08% Shs Outstand34.32M Perf Week-8.89%
Market Cap53.52M Forward P/E1.67 EPS next Y0.74 Insider Trans0.00% Shs Float32.88M Perf Month41.40%
Income-16.80M PEG- EPS next Q-0.11 Inst Own17.10% Short Float9.92% Perf Quarter89.23%
Sales- P/S- EPS this Y33.90% Inst Trans45.54% Short Ratio1.04 Perf Half Y31.12%
Book/sh0.65 P/B1.89 EPS next Y262.20% ROA-63.40% Target Price- Perf Year16.04%
Cash/sh0.10 P/C12.45 EPS next 5Y- ROE-75.80% 52W Range0.40 - 1.97 Perf YTD20.59%
Dividend- P/FCF- EPS past 5Y-6.20% ROI- 52W High-37.56% Beta1.79
Dividend %- Quick Ratio1.40 Sales past 5Y- Gross Margin- 52W Low207.50% ATR0.17
Employees1 Current Ratio1.40 Sales Q/Q- Oper. Margin- RSI (14)54.14 Volatility12.96% 15.81%
OptionableNo Debt/Eq0.01 EPS Q/Q34.40% Profit Margin- Rel Volume0.49 Prev Close1.34
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume3.13M Price1.23
Recom2.00 SMA2012.26% SMA5025.09% SMA20056.74% Volume1,548,563 Change-8.21%
Jul-14-20 08:47AM  
Jul-13-20 08:15AM  
Jun-30-20 08:54AM  
Jun-29-20 09:07AM  
08:35AM  
Jun-26-20 09:00AM  
Jun-23-20 08:49AM  
Jun-22-20 01:17PM  
Jun-02-20 09:30AM  
May-26-20 08:15AM  
May-18-20 02:30PM  
May-15-20 06:49AM  
May-14-20 09:00AM  
May-13-20 08:15AM  
May-12-20 08:00AM  
Apr-27-20 09:30AM  
Apr-01-20 08:07AM  
Mar-26-20 09:06AM  
Mar-18-20 09:46AM  
Mar-16-20 06:22AM  
Mar-03-20 04:45PM  
Feb-26-20 08:00AM  
Feb-25-20 08:00AM  
Feb-10-20 08:28AM  
Feb-04-20 08:00AM  
Feb-03-20 08:00AM  
Jan-27-20 08:00AM  
Dec-19-19 08:00AM  
Dec-04-19 08:00AM  
Nov-08-19 08:00AM  
Oct-24-19 08:00AM  
Oct-15-19 08:00AM  
08:00AM  
08:00AM  
Oct-07-19 08:30AM  
Oct-03-19 07:00AM  
Sep-28-19 07:52AM  
Sep-27-19 11:28AM  
Sep-25-19 07:00AM  
Sep-04-19 06:55AM  
Aug-29-19 08:00AM  
Jul-30-19 08:00AM  
Jul-24-19 03:38PM  
May-24-19 08:53AM  
May-13-19 08:47AM  
May-01-19 08:00AM  
Apr-30-19 09:45AM  
Apr-23-19 08:30AM  
Apr-05-19 07:15PM  
Apr-04-19 08:30AM  
Apr-01-19 09:00AM  
Mar-12-19 08:45AM  
Mar-11-19 02:23PM  
Feb-27-19 12:30PM  
Jan-25-19 08:00AM  
Jan-08-19 09:00AM  
Jan-04-19 10:45AM  
Dec-19-18 09:45AM  
Dec-10-18 08:35AM  
Dec-04-18 08:35AM  
Nov-30-18 08:00AM  
Nov-29-18 04:35PM  
Oct-25-18 08:00AM  
Oct-23-18 08:00AM  
Sep-27-18 08:00AM  
Sep-25-18 08:00AM  
Aug-15-18 08:00AM  
Aug-13-18 05:00PM  
Aug-09-18 01:55PM  
06:00AM  
Jul-31-18 09:30AM  
Jul-24-18 08:00AM  
Jul-13-18 10:48AM  
Jul-09-18 08:00AM  
Jun-19-18 08:00AM  
Mar-29-18 08:00AM  
Mar-06-18 08:00AM  
Feb-15-18 08:00AM  
Feb-13-18 08:00AM  
Jan-31-18 08:00AM  
Jan-04-18 08:00AM  
Dec-18-17 08:00AM  
Dec-06-17 08:00AM  
Dec-04-17 01:36PM  
Nov-14-17 08:00AM  
Nov-07-17 08:00AM  
Oct-31-17 07:15PM  
08:00AM  
Oct-17-17 09:00AM  
Oct-11-17 09:00AM  
Sep-26-17 03:47PM  
Sep-05-17 07:00AM  
Aug-10-17 11:30AM  
Aug-08-17 11:25AM  
Aug-03-17 09:31AM  
Jun-13-17 10:37AM  
Jun-08-17 05:00PM  
Jun-06-17 12:30PM  
Mar-23-17 07:00AM  
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of infected central venous catheters in patients with catheter related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction tissue expander infections following breast reconstructive surgeries; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for the treatment of hemorrhoids. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.